Results 201 to 210 of about 236,049 (260)
Some of the next articles are maybe not open access.
Ischemic Heart Disease in Chronic Uremia
Blood Purification, 2008The burden of ischemic heart disease is high in dialysis patients. Ischemia may result from atherosclerotic and nonatherosclerotic disease and may cause myocardial infarction and angina. The impact of diminished perfusion is intricately associated with the underlying cardiomyopathy, both of which predispose to heart failure. The etiology of ischemia is
P S, Parfrey, R N, Foley
openaire +2 more sources
The Management of Chronic Ischemic Heart Disease in the Elderly
The American Journal of Geriatric Cardiology, 2000Despite advances in medical and surgical therapy, ischemic heart disease remains the most important cause of death and disability in an ever growing population. The management of elderly patients with ischemic heart disease is made more difficult by the presence of comorbid medical conditions, which can both further aggravate ischemic ...
Juan C., Kaski, David A., Smith
openaire +2 more sources
Choice of therapy in chronic ischemic heart disease
The American Journal of Cardiology, 1987The choice of therapy in chronic ischemic heart disease depends on identifying the underlying mechanism. Ambulatory monitoring provides a means of identifying those patients in whom increased myocardial oxygen demand is the most important mechanism and who will respond to a beta blocker.
K M, Fox, R D, Levy, A A, Quyyumi
openaire +2 more sources
Chronic Ischemic Heart Disease
2001The pathophysiology of myocardial ischemia is related to a mismatch between coronary blood flow and myocardial oxygen requirements. In most patients with coronary artery disease, the angina threshold is not fixed but varies throughout the day. The exercise test is probably still the most important noninvasive diagnostic test.
Tomasz Stys +2 more
openaire +1 more source
Chronic Ischemic Heart Disease
2014Chronic ischemic cardiomyopathy (ICMP) is a major and growing problem. Coronary artery disease (CAD) is the leading cause of heart failure and left ventricular systolic dysfunction. To help differentiate between ICMP and non-ischemic cardiomyopathy (NICMP), coronary angiography (CA) has long been considered the test of choice for establishing the ...
Ki Seok Choo, Yeon Hyeon Choe
openaire +1 more source
Management of Ischemic Heart Disease in Patients with Chronic Kidney Disease
American Journal of Cardiovascular Drugs, 2008Patients with chronic kidney disease (CKD) and ischemic heart disease (IHD) have strikingly high mortality rates. In the general population, there has been a reduction in the mortality and morbidity rates for IHD through the implementation of effective risk-factor-reduction programs and better interventions for patients with established IHD.
Arif, Mutwali +2 more
openaire +2 more sources
Magnesium levels in patients with chronic ischemic heart disease
The American Journal of Clinical Nutrition, 1978Serum magnesium was measured in 89 control subjects ages 19 to 86 years and in 64 patients (ages 35 to 82 years) who had suffered from acute myocardial infarction at least 6 months previously. No differences were found in the serum magnesium levels due to age or sex nor was there any statistical difference between the mean levels in the two groups.
A S, Abraham +3 more
openaire +2 more sources
Cell Therapy for the Treatment of Chronic Ischemic Heart Disease
Current Pharmaceutical Design, 2011Over the last decade, much was learned about the biology of several types of stem and progenitor cells. It has become apparent that various cell sources may have the capacity to promote cardiomyogenesis and new blood vessel formation through different mechanisms, forming the rationale for cell-based therapy in patients with chronic ischemic heart ...
Rodrigo, S.F. +5 more
openaire +3 more sources
Changing Scenario in Chronic Ischemic Heart Disease: Therapeutic Implications
The American Journal of Cardiology, 2006Over the last 30 years, considerable progress has been made in drug therapy for chronic ischemic heart disease (IHD). Most pharmacologic therapies act by reducing myocardial oxygen consumption, increasing coronary blood flow, improving ventricular relaxation, dilating collateral vessels, and reducing peripheral resistances.
MARZILLI, MARIO, AFFINITO S, FOCARDI M.
openaire +4 more sources
Renal artery stenting in patients with chronic ischemic heart disease
Catheterization and Cardiovascular Interventions, 2010AbstractObjectives: To investigate the role of renal stenting in selected patients with chronic ischemic heart disease and renal artery stenosis. Methods: Consecutive patients, with chronic ischemic heart disease and severe hypertension and/or impaired renal function undergoing renal stenting, were prospectively enrolled.
Trani, Carlo +14 more
openaire +6 more sources